ATE345503T1 - Krebsdiagnoseverfahren - Google Patents

Krebsdiagnoseverfahren

Info

Publication number
ATE345503T1
ATE345503T1 AT02716509T AT02716509T ATE345503T1 AT E345503 T1 ATE345503 T1 AT E345503T1 AT 02716509 T AT02716509 T AT 02716509T AT 02716509 T AT02716509 T AT 02716509T AT E345503 T1 ATE345503 T1 AT E345503T1
Authority
AT
Austria
Prior art keywords
cells
cyclin
protein
type
sample
Prior art date
Application number
AT02716509T
Other languages
English (en)
Inventor
Fredrik Erlandsson
Anders Zetterberg
Original Assignee
Fredrik Erlandsson
Anders Zetterberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fredrik Erlandsson, Anders Zetterberg filed Critical Fredrik Erlandsson
Application granted granted Critical
Publication of ATE345503T1 publication Critical patent/ATE345503T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57595—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving intracellular compounds

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT02716509T 2001-01-24 2002-01-24 Krebsdiagnoseverfahren ATE345503T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0100197A SE0100197L (sv) 2001-01-24 2001-01-24 Metod för diagnosticering av cancer i vävnad

Publications (1)

Publication Number Publication Date
ATE345503T1 true ATE345503T1 (de) 2006-12-15

Family

ID=20282710

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02716509T ATE345503T1 (de) 2001-01-24 2002-01-24 Krebsdiagnoseverfahren

Country Status (10)

Country Link
US (1) US20040115746A1 (de)
EP (1) EP1354210B1 (de)
JP (1) JP2004529322A (de)
CN (1) CN1502044A (de)
AT (1) ATE345503T1 (de)
CA (1) CA2435210A1 (de)
DE (1) DE60216045T2 (de)
ES (1) ES2276922T3 (de)
SE (1) SE0100197L (de)
WO (1) WO2002059616A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101429540B (zh) * 2007-11-09 2013-07-10 北京雅康博生物科技有限公司 实时定量pcr检测细胞周期蛋白b2基因表达的方法
WO2014110510A1 (en) * 2013-01-14 2014-07-17 Incelldx, Inc. Methods for determining whether a cervical cellular sample should be tested for cervical cancer, and devices and kits for practicing the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5543291A (en) * 1993-01-29 1996-08-06 Dana Farber Cancer Institute Method of detecting carcinoma

Also Published As

Publication number Publication date
JP2004529322A (ja) 2004-09-24
SE0100197L (sv) 2002-07-25
DE60216045T2 (de) 2007-07-05
EP1354210B1 (de) 2006-11-15
CA2435210A1 (en) 2002-08-01
CN1502044A (zh) 2004-06-02
US20040115746A1 (en) 2004-06-17
WO2002059616A1 (en) 2002-08-01
EP1354210A1 (de) 2003-10-22
ES2276922T3 (es) 2007-07-01
DE60216045D1 (de) 2006-12-28
SE0100197D0 (sv) 2001-01-24

Similar Documents

Publication Publication Date Title
AU2001253079A1 (en) Methods, compositions and kits for the detection and monitoring of breast cancer
DE69907155D1 (de) Krebsbehandlung
WO2003062401A3 (en) Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
EP1870466A3 (de) Zusammensetzungen und Verfahren zur Behandlung und Diagnose von Prostatakrebs
ATE194660T1 (de) Veraendertes gen bei menschlichem colorektalem- krebs
ATE369425T1 (de) Antikörper gegen eine lar-phosphatase untereinheit
WO2004032621A3 (en) Techniques for identifying molecular structures and treating cell types lining a body lumen using fluorescence
TR200003903T2 (tr) Karsinomların erken teşhisi için yöntem
WO2002083070A3 (en) Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
ES2171219T3 (es) Deteccion precoz de cancer de prostata (cap) por determinacion de una relacion entre las concentraciones de antigeno especifico de prostata (psa) y calicreina glandular humana (hgk-1).
WO2003025141A3 (en) Genetic analysis for stratification of cancer risk
DE60032784D1 (de) Markerproteine für prostatakrebs
DK1083824T3 (da) Kalibreringsvæske til en sensor til måling af en blodværdi samt fremstilling af kalibreringsvæsken
EP1377596A4 (de) Ttk in der diagnose und als therapeutisches target bei krebs
ATE466938T1 (de) Prostata-spezifisches gen pcgem1 und methoden zu dessen verwendung zur erkennung, behandlung und prävention von prostatakrebs
WO2005024067A3 (en) Genetic analysis for stratification of breast cancer risk
TR200101702T2 (tr) Mammaglobin, göğse özgü salgılanan bir göğüs kanseri proteini.
ATE345503T1 (de) Krebsdiagnoseverfahren
BR0209172A (pt) Método de detecção de doenças induzidas por glúten em uma amostra sanguìnea de um indivìduo, e kit teste para uso no método
Müezzinoğlu et al. Population standards of prostate specific antigen values in men over 40: community based study in Turkey
BR0012301A (pt) Inibidores de crescimento de células epiteliais
CN214538872U (zh) 一种鼻咽上皮细胞tcph+ros特殊染色试剂盒
Zach et al. Mammaglobin remains a useful marker for the detection of breast cancer cells in peripheral blood
FR2849203B1 (fr) Methode d'analyse de l'agressivite tumorale de cellules cancereuses comprenant la mesure de la quantite d'actine polymerisee a l'etat stationnaire
DE60328770D1 (de) Ein neuer biologischer tumormarker und methoden für die detektion des krebsartigen oder nicht krebsartigen phenotyps von zellen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties